121 related articles for article (PubMed ID: 33189577)
1. TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
Erkul E; Yilmaz I
Oral Oncol; 2021 Mar; 114():105089. PubMed ID: 33189577
[TBL] [Abstract][Full Text] [Related]
2. TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Giunco S; Rampazzo E; Brutti M; Spinato G; Menegaldo A; Stellin M; Mantovani M; Bandolin L; Rossi M; Del Mistro A; Tirelli G; Dei Tos AP; Guerriero A; Niero M; Da Mosto MC; Polesel J; De Rossi A
J Cancer Res Clin Oncol; 2020 Feb; 146(2):381-389. PubMed ID: 31960186
[TBL] [Abstract][Full Text] [Related]
3. TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
Vinothkumar V; Arunkumar G; Revathidevi S; Arun K; Manikandan M; Rao AK; Rajkumar KS; Ajay C; Rajaraman R; Ramani R; Murugan AK; Munirajan AK
Tumour Biol; 2016 Jun; 37(6):7907-13. PubMed ID: 26700669
[TBL] [Abstract][Full Text] [Related]
4. Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma.
Yilmaz I; Erkul BE; Ozturk Sari S; Issin G; Tural E; Terzi Kaya Terzi N; Karatay H; Celik M; Ulusan M; Bilgic B
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Jul; 130(1):63-70. PubMed ID: 32404253
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma.
Chang KP; Wang CI; Pickering CR; Huang Y; Tsai CN; Tsang NM; Kao HK; Cheng MH; Myers JN
Head Neck; 2017 Jun; 39(6):1131-1137. PubMed ID: 28230921
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Muggia F
Oncologist; 2013; 18(3):245-7. PubMed ID: 23485623
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics.
Zhou WN; Du YF; Zheng Y; Zhang W; Wu YN; Song XM; Bai J
Mol Med Rep; 2019 Feb; 19(2):885-894. PubMed ID: 30535462
[TBL] [Abstract][Full Text] [Related]
9. Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia.
Scholz SL; Thomasen H; Reis H; Möller I; Darawsha R; Müller B; Dekowski D; Sucker A; Schilling B; Schadendorf D; Steuhl KP; Paschen A; Westekemper H; Meller D; Griewank KG
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5854-61. PubMed ID: 26348634
[TBL] [Abstract][Full Text] [Related]
10.
Yu Y; Fan D; Song X; Zakeri K; Chen L; Kang J; McBride S; Tsai CJ; Dunn L; Sherman E; Katabi N; Dogan S; Cracchiolo J; Cohen M; Boyle JO; Lee M; Valero C; Wang J; Wong R; Morris L; Riaz N; Lee N
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34381934
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.
Cheng KA; Kurtis B; Babayeva S; Zhuge J; Tantchou I; Cai D; Lafaro RJ; Fallon JT; Zhong M
Ann Diagn Pathol; 2015 Jun; 19(3):146-8. PubMed ID: 25862495
[TBL] [Abstract][Full Text] [Related]
12. TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features.
Kim SK; Kim JH; Han JH; Cho NH; Kim SJ; Kim SI; Choo SH; Kim JS; Park B; Kwon JE
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1125-1135. PubMed ID: 33635430
[TBL] [Abstract][Full Text] [Related]
13. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
[TBL] [Abstract][Full Text] [Related]
14. Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma.
Priemer DS; Wang M; Zhang S; Lopez-Beltran A; Kouba E; Montironi R; Davidson DD; MacLennan GT; Wang L; Osunkoya AO; Deng Y; Emerson RE; Cheng L
Eur Urol Focus; 2018 Dec; 4(6):880-888. PubMed ID: 28753872
[TBL] [Abstract][Full Text] [Related]
15. TERT promoter mutations in head and neck squamous cell carcinoma: A systematic review and meta-analysis on prevalence and prognostic significance.
Boscolo-Rizzo P; Tirelli G; Polesel J; Sia E; Phillips V; Borsetto D; De Rossi A; Giunco S
Oral Oncol; 2023 May; 140():106398. PubMed ID: 37075587
[TBL] [Abstract][Full Text] [Related]
16. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Kim S; Lee C; Kim H; Yoon SO
Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
[TBL] [Abstract][Full Text] [Related]
17. High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.
Zheng X; Zhuge J; Bezerra SM; Faraj SF; Munari E; Fallon JT; Yang XJ; Argani P; Netto GJ; Zhong M
J Hematol Oncol; 2014 Jul; 7():47. PubMed ID: 25042800
[TBL] [Abstract][Full Text] [Related]
18. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
Thiem S; Herold T; Krafft U; Bremmer F; Tolkach Y; Szász AM; Kriegsmann J; Gaisa NT; Niedworok C; Szarvas T; Reis H
Pathol Int; 2017 Dec; 67(12):597-601. PubMed ID: 29047227
[TBL] [Abstract][Full Text] [Related]
19. Genomic and epigenetic characterization for the comparison of synchronous bilateral tongue squamous cell carcinomas-A case report.
Ribeiro IP; Barroso L; Marques F; Santos A; Caramelo F; Julião MJ; Melo JB; Carreira IM
Curr Probl Cancer; 2017; 41(6):398-406. PubMed ID: 29056289
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma.
Jayaraj P; Sen S; Saxena K; Gupta J; Vats P; Kashyap S; Chauhan S; Pushker N
Indian J Ophthalmol; 2022 Mar; 70(3):971-975. PubMed ID: 35225554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
